Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PFX Stock Summary
Top 10 Correlated ETFs
PFX
In the News
PFX Financial details
Company Rating
Neutral
Market Cap
91.18M
Income
27.5M
Revenue
35.19M
Book val./share
72.71
Cash/share
107112.63
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.07
Forward P/E
-
PEG
0
P/S
2.6
P/B
0.63
P/C
0
P/FCF
-4.4
Quick Ratio
3.06
Current Ratio
3.06
Debt / Equity
0.56
LT Debt / Equity
0.56
-
-
EPS (TTM)
13.17
EPS next Y
-
EPS next Q
-
EPS this Y
-602.73%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-5.44%
Revenue Q/Q
-38.32%
EPS Q/Q
-37.78%
-
-
-
-
SMA20
-2.22%
SMA50
-2.22%
SMA100
18.92%
Inst Own
26.71%
Inst Trans
0.93%
ROA
-541%
ROE
-956%
ROC
3.81%
Gross Margin
-8291%
Oper. Margin
2569%
Profit Margin
-3703%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
32.0-45.5
52W High
-0.96%
52W Low
+39.27%
RSI
42
Rel Volume
0.1
Avg Volume
4.85K
Volume
471
Perf Week
1.27%
Perf Month
-0.54%
Perf Quarter
22.1%
Perf Half Y
19.04%
-
-
-
-
Beta
1.024
-
-
Volatility
0.64%, 0.71%
Prev Close
2.97%
Price
44.567
Change
2.97%
PFX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 17 | 7.9 | 3.08 | 0.51 | 16.73 | |
Net income per share | -35.46 | -24.16 | 0.48 | -2.56 | 12.87 | |
Operating cash flow per share | 65.93 | 28.77 | 35.52 | -12.61 | -9.9 | |
Free cash flow per share | 65.93 | 28.77 | 35.52 | -12.61 | -9.9 | |
Cash per share | 25.06 | 20.75 | 25.93 | 62.57 | 108.13K | |
Book value per share | 79.46 | 55.3 | 53.66 | 52.01 | 70.12 | |
Tangible book value per share | 79.46 | 55.3 | 53.66 | 52.01 | 70.12 | |
Share holders equity per share | 79.46 | 55.3 | 53.66 | 52.01 | 70.12 | |
Interest debt per share | 92.52K | 88.08 | 31.11 | 69.31 | 42.99 | |
Market cap | 141.09M | 48.56M | 114.88M | 81.05M | 79.3M | |
Enterprise value | 324.58M | 143M | 122.88M | 136.24M | 157.56M | |
P/E ratio | -1.46 | -0.74 | 89.9 | -13.6 | 2.95 | |
Price to sales ratio | 3.05 | 2.26 | 13.95 | 68.18 | 2.27 | |
POCF ratio | 0.79 | 0.62 | 1.21 | -2.77 | -3.83 | |
PFCF ratio | 0.79 | 0.62 | 1.21 | -2.77 | -3.83 | |
P/B Ratio | 0.65 | 0.32 | 0.8 | 0.67 | 0.54 | |
PTB ratio | 0.65 | 0.32 | 0.8 | 0.67 | 0.54 | |
EV to sales | 7.01 | 6.64 | 14.92 | 114.61 | 4.5 | |
Enterprise value over EBITDA | -3.36 | -2.17 | 96.16 | -137.09 | 0.03 | |
EV to operating cash flow | 1.81 | 1.82 | 1.29 | -4.65 | -7.61 | |
EV to free cash flow | 1.81 | 1.82 | 1.29 | -4.65 | -7.61 | |
Earnings yield | -0.68 | -1.36 | 0.01 | -0.07 | 0.34 | |
Free cash flow yield | 1.27 | 1.61 | 0.83 | -0.36 | -0.26 | |
Debt to equity | 1.16K | 1.49 | 0.54 | 1.29 | 0.58 | |
Debt to assets | 518.2 | 0.73 | 0.34 | 0.71 | 0.35 | |
Net debt to EBITDA | -1.9 | -1.43 | 6.26 | -55.54 | 0.01 | |
Current ratio | 4.73 | 19.68 | 50.86 | 0.56 | 16.5 | |
Interest coverage | -4.02 | -4.41 | 0.22 | -0.22 | 1.01K | |
Income quality | -1.86 | -1.19 | 74.44 | 4.8 | -0.77 | |
Dividend Yield | 0.06 | 0 | 0 | 0 | 1.36 | |
Payout ratio | -0.08 | 0 | 0 | -0.04 | 4.01 | |
Sales general and administrative to revenue | 0.69 | 0.17 | 0.59 | 3.4 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 251.78 | 173.39 | 24 | 54.78 | 142.47 | |
ROIC | -0.03 | -0.15 | -0.07 | 0 | 13.31 | |
Return on tangible assets | -0.2 | -0.22 | 0.01 | -0.03 | 0.11 | |
Graham Net | -73.43 | -25.62 | -3.74 | 20.84 | 108.09K | |
Working capital | 55.5M | 54.36M | 70.63M | -1.13M | 6.54B | |
Tangible asset value | 216.43M | 150.62M | 143.69M | 120.85M | 146.71M | |
Net current asset value | -199.47M | -98.22M | -9.35M | -96.61M | 6.87B | |
Invested capital | 1.16K | 1.49 | 0.54 | 1.29 | 0.58 | |
Average receivables | 4.42M | 1.43M | 1.68M | 2.02M | 3.47M | |
Average payables | 10.54M | 8.89M | 2.16M | 1.98M | 5.21M | |
Average inventory | 0.5 | 28.63M | 28.63M | 0.5 | 1 | |
Days sales outstanding | 16.71 | 12.62 | 115.97 | 435.49 | 57.48 | |
Days payables outstanding | 49.81 | 7.46 | 293.87 | 0.31 | 0.69 | |
Days of inventory on hand | 0 | 146.9 | 0 | 0 | 0 | |
Receivables turnover | 21.84 | 28.93 | 3.15 | 0.84 | 6.35 | |
Payables turnover | 7.33 | 48.9 | 1.24 | 1.16K | 531.3 | |
Inventory turnover | 108.91M | 2.48 | 0 | 2.95B | 4.19B | |
ROE | -0.45 | -0.44 | 0.01 | -0.05 | 0.18 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q1
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.75 | 4.04 | 5.32 | 4.63 | 2.87 | |
Net income per share | 1.88 | 3.2 | 4.26 | 3.52 | 2.19 | |
Operating cash flow per share | -2.29 | -3.17 | -2.28 | -2.15 | 3.26 | |
Free cash flow per share | -2.29 | -3.17 | -2.28 | -2.15 | 3.26 | |
Cash per share | 67.06 | 95.41K | 104.5K | 2.87 | 107.11K | |
Book value per share | 59.35 | 62.6 | 66.94 | 70.41 | 72.71 | |
Tangible book value per share | 59.35 | 62.6 | 66.94 | 70.41 | 72.71 | |
Share holders equity per share | 59.35 | 62.6 | 66.94 | 70.41 | 72.71 | |
Interest debt per share | 74.9 | 38.34 | 40.85 | -159.42 | 41.49 | |
Market cap | 65.23M | 77.52M | 79.45M | 78.97M | 87.57M | |
Enterprise value | 125.64M | 145.64M | 152.53M | 157.24M | 159.73M | |
P/E ratio | 4.13 | 2.89 | 2.23 | 2.69 | 4.83 | |
Price to sales ratio | 11.3 | 9.16 | 7.14 | 8.18 | 14.71 | |
POCF ratio | -13.59 | -11.66 | -16.64 | -17.61 | 12.97 | |
PFCF ratio | -13.59 | -11.66 | -16.64 | -17.61 | 12.97 | |
P/B Ratio | 0.52 | 0.59 | 0.57 | 0.54 | 0.58 | |
PTB ratio | 0.52 | 0.59 | 0.57 | 0.54 | 0.58 | |
EV to sales | 21.76 | 17.21 | 13.71 | 16.3 | 26.84 | |
Enterprise value over EBITDA | 43.14 | 0.11 | 0.17 | 21.42 | 26.29 | |
EV to operating cash flow | -26.17 | -21.91 | -31.95 | -35.07 | 23.65 | |
EV to free cash flow | -26.17 | -21.91 | -31.95 | -35.07 | 23.65 | |
Earnings yield | 0.06 | 0.09 | 0.11 | 0.09 | 0.05 | |
Free cash flow yield | -0.07 | -0.09 | -0.06 | -0.06 | 0.08 | |
Debt to equity | 1.25 | 0.6 | 0.6 | -2.27 | 0.56 | |
Debt to assets | 0.76 | 0.37 | 0.36 | -1.39 | 0.36 | |
Net debt to EBITDA | 20.74 | 0.05 | 0.08 | 10.66 | 11.88 | |
Current ratio | 1.79 | 34.24 | 45.99 | 3.06 | 5.81K | |
Interest coverage | 2.34 | 5.86 | 622.53 | 4.89 | 3.94 | |
Income quality | -1.21 | -0.99 | -0.54 | -0.61 | 1.49 | |
Dividend Yield | 0 | 0 | 0 | 1.37 | 0.93 | |
Payout ratio | 0 | 0 | 0 | 14.69 | 18.05 | |
Sales general and administrative to revenue | 0.17 | 0.11 | 0.08 | 0.11 | 0.18 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 50.12 | 67.15 | 80.15 | 74.71 | 59.82 | |
ROIC | 0.01 | 0.04 | 2.77 | -18.15 | 0.03 | |
Return on tangible assets | 0.02 | 0.03 | 0.04 | 0.03 | 0.02 | |
Graham Net | 29.61 | 95.55K | 104.67K | -39.77 | 107.41K | |
Working capital | 63.01M | 11.15B | 11.49B | 7.74M | 13.57B | |
Tangible asset value | 124.69M | 131.15M | 139.95M | 146.71M | 150.7M | |
Net current asset value | 61.91M | 11.41B | 11.65B | -81.49M | 13.49B | |
Invested capital | 1.25 | 0.6 | 0.6 | -2.27 | 0.56 | |
Average receivables | 2.05M | 2.04M | 1.44M | 3.5M | 3.79M | |
Average payables | 2.04M | 1.79M | 4.92M | 5.78M | 3.05M | |
Average inventory | 1 | 368.21M | 806.37M | 438.17M | 706.16M | |
Days sales outstanding | 41.83 | 14.76 | 12.05 | 51.42 | 31.16 | |
Days payables outstanding | 0.16 | 0.23 | 0.55 | 0.27 | 2.7K | |
Days of inventory on hand | 0 | 82.63 | 61.72 | 0 | 1.63M | |
Receivables turnover | 2.15 | 6.1 | 7.47 | 1.75 | 2.89 | |
Payables turnover | 554.94 | 393.22 | 163.68 | 332.53 | 0.03 | |
Inventory turnover | 857.53M | 1.09 | 1.46 | 1.25B | 0 | |
ROE | 0.03 | 0.05 | 0.06 | 0.05 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PFX Frequently Asked Questions
What is PhenixFIN Corporation stock symbol ?
PhenixFIN Corporation is a US stock , located in New york of Ny and trading under the symbol PFX
What is PhenixFIN Corporation stock quote today ?
PhenixFIN Corporation stock price is $44.567 today.
Is PhenixFIN Corporation stock public?
Yes, PhenixFIN Corporation is a publicly traded company.